Figure 7: Evaluation of the antimicrobial and antibiofilm activity of Clavanina A against MRSA, K. pneumoniae 1825971 (KpC isolate) and E. coli (O157).
From: Structural Studies of a Lipid-Binding Peptide from Tunicate Hemocytes with Anti-Biofilm Activity

MIC, minimal inhibitory concentration; MBIC, minimal biofilm inhibitory concentration; (C) control growth (bacteria withouth any treatment). Clavanin exhibit a dose-dependent anti-biofilm activity against E.coli and MRSA.